Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELON CORP Director's Dealing 2021

Jan 20, 2021

30044_dirs_2021-01-20_ee5a5421-0143-40bd-b5cc-76872e414979.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: EXELON CORP (EXC)
CIK: 0001109357
Period of Report: 2020-12-31

Reporting Person: Crane Christopher M. (Director, President and CEO)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 437997 Direct
Common Stock 28500 Indirect
Common Stock 28500 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
2018 Restricted Stock Unit Awards $0 Common Stock (32075) 32075 Direct
2019 Restricted Stock Unit Awards $0 Common Stock (54743) 54743 Direct
2020 Restricted Stock Unit Awards $0 Common Stock (79784) 79784 Direct
Deferred Compensation Equivalent Shares $0 Common Stock (6977) 6977 Direct
NQ Stock Option (right to buy) 04/02/2012 $39.21 Common Stock (285000) 285000 Direct
NQ Stock Option (right to buy) 01/24/2011 $43.4 Common Stock (94000) 94000 Direct

Footnotes

F1: Previously awarded restricted stock units (RSUs) granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development committee's first meeting in January or February and vest in 1/3 increments on the date of the committee's first annual meeting in the first, second and third years after the award was granted. Award balances accrue addtional RSUs through quarterly dividend reinvestment that vest on the same schedule as the underlying award.

F2: Balance includes 1,202 shares acquired through quarterly dividend reinvestment during 2020.

F3: Balance includes 2,052 shares acquired through quarterly dividend reinvestment during 2020.

F4: Balance includes 2,991 shares acquired through quarterly dividend reinvestment during 2020.

F5: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the company for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions, company matching contributions and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate due to periodic changes in the fund composition.

F6: Balance includes 250 share equivalents accrued through quarterly dividend reinvestment during 2020.

F7: Non qualified employee stock options, awarded pursuant to the Exelon Long Term Incentive Plan. Options are fully vested and expire on the tenth anniversay of the grant date referenced in Column 1.